Sensitizing human multiple myeloma cells to the proteasome inhibitor bortezomib by novel curcumin analogs

The proteasome plays a vital role in the degradation of proteins involved in several pathways including the cell cycle, cellular proliferation and apoptosis and is a validated target in cancer treatment. Bortezomib (Velcade(®), PS-341) is the first US FDA approved proteasome inhibitor anticancer dru...

Descripción completa

Detalles Bibliográficos
Autores principales: MUJTABA, TASKEEN, KANWAR, JYOTI, WAN, SHENG BIAO, CHAN, TAK HANG, DOU, Q. PING
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2012
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3307794/
https://www.ncbi.nlm.nih.gov/pubmed/22012631
http://dx.doi.org/10.3892/ijmm.2011.814

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3307794/
https://www.ncbi.nlm.nih.gov/pubmed/22012631
http://dx.doi.org/10.3892/ijmm.2011.814

Ejemplares similares